Cargando…
(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial
BACKGROUND: The time to diagnosis of invasive Candida infection (ICI) is often too long to initiate timely antifungal therapy in patients with sepsis. Elevated serum (1,3)-β-D-glucan (BDG) concentrations have a high diagnostic sensitivity for detecting ICI. However, the clinical significance of elev...
Autores principales: | Bloos, Frank, Held, Jürgen, Schlattmann, Peter, Brillinger, Nicole, Kurzai, Oliver, Cornely, Oliver A., Thomas-Rüddel, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124015/ https://www.ncbi.nlm.nih.gov/pubmed/30180873 http://dx.doi.org/10.1186/s13063-018-2868-0 |
Ejemplares similares
-
(1 → 3)-β-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial
por: Bloos, Frank, et al.
Publicado: (2022) -
Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis
por: Thomas-Rüddel, Daniel O., et al.
Publicado: (2022) -
Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection—A Prospective Pilot Study
por: Koehler, Felix C., et al.
Publicado: (2018) -
T2Candida for the Diagnosis and Management of Invasive Candida Infections
por: Monday, Lea M, et al.
Publicado: (2021) -
Host response to Candida albicans bloodstream infection and sepsis
por: Duggan, Seána, et al.
Publicado: (2015)